Fig. 1.
GPCR-targeted orthosteric small molecules may exhibit disadvantages such as difficulty binding diffuse orthosteric sites with high affinity, unintended kinetic or physiological effects from exclusively occupying the orthosteric site, and off-target effects through poor selectivity between highly homologous receptor subtypes.